Cargando…

Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models

BACKGROUND: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in early-onset pre-eclampsia. To safely prolong preterm gestation, accurate and timely prediction of complications is required. METHOD: Women with confirmed early onset pre-eclampsia were recruited from 53...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangaratinam, Shakila, Allotey, John, Marlin, Nadine, Dodds, Julie, Cheong-See, Fiona, von Dadelszen, Peter, Ganzevoort, Wessel, Akkermans, Joost, Kerry, Sally, Mol, Ben W., Moons, Karl G. M., Riley, Richard D., Khan, Khalid S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372261/
https://www.ncbi.nlm.nih.gov/pubmed/28356148
http://dx.doi.org/10.1186/s12916-017-0827-3
_version_ 1782518580058783744
author Thangaratinam, Shakila
Allotey, John
Marlin, Nadine
Dodds, Julie
Cheong-See, Fiona
von Dadelszen, Peter
Ganzevoort, Wessel
Akkermans, Joost
Kerry, Sally
Mol, Ben W.
Moons, Karl G. M.
Riley, Richard D.
Khan, Khalid S.
author_facet Thangaratinam, Shakila
Allotey, John
Marlin, Nadine
Dodds, Julie
Cheong-See, Fiona
von Dadelszen, Peter
Ganzevoort, Wessel
Akkermans, Joost
Kerry, Sally
Mol, Ben W.
Moons, Karl G. M.
Riley, Richard D.
Khan, Khalid S.
author_sort Thangaratinam, Shakila
collection PubMed
description BACKGROUND: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in early-onset pre-eclampsia. To safely prolong preterm gestation, accurate and timely prediction of complications is required. METHOD: Women with confirmed early onset pre-eclampsia were recruited from 53 maternity units in the UK to a large prospective cohort study (PREP-946) for development of prognostic models for the overall risk of experiencing a complication using logistic regression (PREP-L), and for predicting the time to adverse maternal outcome using a survival model (PREP-S). External validation of the models were carried out in a multinational cohort (PIERS-634) and another cohort from the Netherlands (PETRA-216). Main outcome measures were C-statistics to summarise discrimination of the models and calibration plots and calibration slopes. RESULTS: A total of 169 mothers (18%) in the PREP dataset had adverse outcomes by 48 hours, and 633 (67%) by discharge. The C-statistics of the models for predicting complications by 48 hours and by discharge were 0.84 (95% CI, 0.81–0.87; PREP-S) and 0.82 (0.80–0.84; PREP-L), respectively. The PREP-S model included maternal age, gestation, medical history, systolic blood pressure, deep tendon reflexes, urine protein creatinine ratio, platelets, serum alanine amino transaminase, urea, creatinine, oxygen saturation and treatment with antihypertensives or magnesium sulfate. The PREP-L model included the above except deep tendon reflexes, serum alanine amino transaminase and creatinine. On validation in the external PIERS dataset, the reduced PREP-S model showed reasonable calibration (slope 0.80) and discrimination (C-statistic 0.75) for predicting adverse outcome by 48 hours. Reduced PREP-L model showed excellent calibration (slope: 0.93 PIERS, 0.90 PETRA) and discrimination (0.81 PIERS, 0.75 PETRA) for predicting risk by discharge in the two external datasets. CONCLUSIONS: PREP models can be used to obtain predictions of adverse maternal outcome risk, including early preterm delivery, by 48 hours (PREP-S) and by discharge (PREP-L), in women with early onset pre-eclampsia in the context of current care. They have a potential role in triaging high-risk mothers who may need transfer to tertiary units for intensive maternal and neonatal care. TRIAL REGISTRATION: ISRCTN40384046, retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0827-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5372261
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53722612017-03-30 Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models Thangaratinam, Shakila Allotey, John Marlin, Nadine Dodds, Julie Cheong-See, Fiona von Dadelszen, Peter Ganzevoort, Wessel Akkermans, Joost Kerry, Sally Mol, Ben W. Moons, Karl G. M. Riley, Richard D. Khan, Khalid S. BMC Med Research Article BACKGROUND: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in early-onset pre-eclampsia. To safely prolong preterm gestation, accurate and timely prediction of complications is required. METHOD: Women with confirmed early onset pre-eclampsia were recruited from 53 maternity units in the UK to a large prospective cohort study (PREP-946) for development of prognostic models for the overall risk of experiencing a complication using logistic regression (PREP-L), and for predicting the time to adverse maternal outcome using a survival model (PREP-S). External validation of the models were carried out in a multinational cohort (PIERS-634) and another cohort from the Netherlands (PETRA-216). Main outcome measures were C-statistics to summarise discrimination of the models and calibration plots and calibration slopes. RESULTS: A total of 169 mothers (18%) in the PREP dataset had adverse outcomes by 48 hours, and 633 (67%) by discharge. The C-statistics of the models for predicting complications by 48 hours and by discharge were 0.84 (95% CI, 0.81–0.87; PREP-S) and 0.82 (0.80–0.84; PREP-L), respectively. The PREP-S model included maternal age, gestation, medical history, systolic blood pressure, deep tendon reflexes, urine protein creatinine ratio, platelets, serum alanine amino transaminase, urea, creatinine, oxygen saturation and treatment with antihypertensives or magnesium sulfate. The PREP-L model included the above except deep tendon reflexes, serum alanine amino transaminase and creatinine. On validation in the external PIERS dataset, the reduced PREP-S model showed reasonable calibration (slope 0.80) and discrimination (C-statistic 0.75) for predicting adverse outcome by 48 hours. Reduced PREP-L model showed excellent calibration (slope: 0.93 PIERS, 0.90 PETRA) and discrimination (0.81 PIERS, 0.75 PETRA) for predicting risk by discharge in the two external datasets. CONCLUSIONS: PREP models can be used to obtain predictions of adverse maternal outcome risk, including early preterm delivery, by 48 hours (PREP-S) and by discharge (PREP-L), in women with early onset pre-eclampsia in the context of current care. They have a potential role in triaging high-risk mothers who may need transfer to tertiary units for intensive maternal and neonatal care. TRIAL REGISTRATION: ISRCTN40384046, retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0827-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-30 /pmc/articles/PMC5372261/ /pubmed/28356148 http://dx.doi.org/10.1186/s12916-017-0827-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Thangaratinam, Shakila
Allotey, John
Marlin, Nadine
Dodds, Julie
Cheong-See, Fiona
von Dadelszen, Peter
Ganzevoort, Wessel
Akkermans, Joost
Kerry, Sally
Mol, Ben W.
Moons, Karl G. M.
Riley, Richard D.
Khan, Khalid S.
Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title_full Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title_fullStr Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title_full_unstemmed Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title_short Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
title_sort prediction of complications in early-onset pre-eclampsia (prep): development and external multinational validation of prognostic models
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372261/
https://www.ncbi.nlm.nih.gov/pubmed/28356148
http://dx.doi.org/10.1186/s12916-017-0827-3
work_keys_str_mv AT thangaratinamshakila predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT alloteyjohn predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT marlinnadine predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT doddsjulie predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT cheongseefiona predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT vondadelszenpeter predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT ganzevoortwessel predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT akkermansjoost predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT kerrysally predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT molbenw predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT moonskarlgm predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT rileyrichardd predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT khankhalids predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels
AT predictionofcomplicationsinearlyonsetpreeclampsiaprepdevelopmentandexternalmultinationalvalidationofprognosticmodels